BioTech 365

APRIL 12, 2021

Abcam and MEDx extend precision medicine strategic partnership Abcam and MEDx extend precision medicine strategic partnership Building on existing three-year collaboration Focusing on co-development of companion and in vitro diagnostic kits to support demand in China CAMBRIDGE, United Kingdom and … Continue reading →

Medicine 40

Medicine In-Vitro Development 40

The Pharma Data

MARCH 23, 2022

Roche today announced the donation of additional medicines and diagnostics to Ukraine. Beyond the already communicated 150,000 packs of an antibiotic medicine the new donation includes another 4,600 packs of specialized medicines for the treatment of influenza, rheumatoid arthritis, SMA and various cancers.

Medicine 52

Medicine In-Vitro Reagent Branding 52

Drug Discovery World

JULY 31, 2023

DDW’s Reece Armstrong speaks to Hendrik Streefkerk , Chief Medical Officer and Drug Safety Officer of CellProthera about the company’s cell therapy for acute myocardial infarction (AMI) and why regenerative medicine could be key to treating cardiac diseases. Unfortunately, this is not enough,” Dr Streefkerk states.

Medicine 52

Medicine Clinical Trials Clinical Trials Manufacturing 52

The Pharma Data

OCTOBER 16, 2020

This week’s round up features a digital solution for adapting clinical trials to ease the burden on the clinical research industry and an in vitro model that mimics the human airway epithelium using a newly developed technology platform. In vitro antiviral technology proves effective against SARS-CoV-2 in human airway infection model.

In-Vitro 52

In-Vitro Clinical Trials Clinical Trials Trials 52

The Pharma Data

MARCH 3, 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial donation of essential medicines to Ukraine. At the same time we are ensuring that our critical medicines and diagnostics reach the people who need them both in Ukraine and other countries impacted by the crisis. Roche vehemently condemns the violent invasion of the country.

Medicine 52

Medicine In-Vitro Packaging Packaging 52

pharmaphorum

JANUARY 25, 2022

For example, there is no need for in vivo animal or in vitro pre-clinical or non-clinical studies. The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the area is mounting. This equated to $21.3

Medicine 108

Medicine In-Vivo In-Vitro Development 108

Medical Xpress

DECEMBER 20, 2022

An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.

In-Vitro 75

In-Vitro Medicine Research 75

Pharmaceutical Technology

APRIL 12, 2023

Foundation Medicine has announced it will supply a tissue-based test as a companion diagnostic for Bristol Myers Squibb’s (BMS) recently acquired ROS1/TRK inhibitor repotrectinib. FoundationOne CDx is a sequencing-based in vitro diagnostic device that can identify alterations in 324 genes from tumour samples.

Genome 130

Genome Genomics In-Vitro Gene 130

Scienmag

OCTOBER 20, 2020

The cover for issue 31 of Oncotarget features Figure 4, ‘Concentration dose-response curves of sirolimus effect [55 nM-1 nM] on the number of cells per surviving colony in U2OS cell line after 2 weeks exposure,’ by Vasuri, et al. Credit: Correspondence to – Gianandrea Pasquinelli – gianandr.pasquinelli@unibo.it

In-Vitro 79

In-Vitro Medicine 79

Drug Discovery World

JANUARY 18, 2023

Accurately predicting the bioavailability of orally administered medicines in humans during preclinical development is crucial as it forms the basis for setting safe and efficacious doses in the clinic. . has removed the mandatory requirement for animal testing for toxicity where enhanced performance is proven using in vitro alternatives.

Bioavailability 52

Bioavailability In-Vitro Research Drugs 52

Pharmaceutical Technology

MAY 31, 2023

It provides medicines for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Buy the report here.

In-Vitro 130

In-Vitro Clinical Trials Clinical Trials Drugs 130

STAT News

JULY 28, 2022

In a big step toward achieving in vitro gametogenesis — one of reproductive medicine’s more ambitious moonshots — the group led by pioneering fertility researcher Shoukrat Mitalipov now intends to use the same method to make artificial human embryos in a test tube. Read the rest…

In-Vitro 98

In-Vitro Research DNA Genetics 98

Scienmag

NOVEMBER 17, 2020

A new paper in JNCI: Journal of the National Cancer Institute, published by Oxford University Press, indicates that receiving assisted reproductive technology does not increase the risk women have for developing ovarian cancer.

In-Vitro 40

In-Vitro Development Research Medicine 40

Scienmag

JANUARY 25, 2022

Vaccination against COVID-19 did not affect fertility outcomes in patients undergoing in-vitro fertilization (IVF), a new study has found. Investigators at the Icahn School of Medicine at […].

Vaccination 57

Vaccination Vaccine In-Vitro Medicine 57

Drug Discovery World

APRIL 24, 2024

Andrew Farnum, CEO at Variant Bio, added: “Evotec has established and validated in vitro and in vivo models to accelerate programme timelines and is ideally positioned to advance our fibrosis programme. They have the experience and track record in converting breakthrough science into medicines that matter for patients.”

Development 52

Development In-Vivo In-Vitro Genome 52

BioSpace

FEBRUARY 16, 2021

In an editorial letter in The New England Journal of Medicine, Jeff Shuren, M.D., the FDA’s device center director, and the agency’s in vitro diagnostics chief Timothy Stenzel, M.D., wrote that the agency planned to revisit their policy on antibody testing after it had authorized several s.

In-Vitro 56

In-Vitro Antibody Medicine 56

Pharmaceutical Technology

NOVEMBER 10, 2022

According to data from vitro studies, the investigational new drugs of the company have been shown to protect mitochondria and enhance human cell viability. Led by Omega Funds, the financing round saw participation from new investor Brandon Capital and founding investor, The Parkinson’s Virtual Biotech. .

Development 130

Development In-Vitro Clinical Development Medicine 130

Drug Discovery World

APRIL 8, 2024

Outstanding Achievement Award Pfizer Chairman and CEO Dr Albert Bourla received the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine on behalf of Pfizer during the Opening Ceremony.

In-Vivo 52

In-Vivo In-Vitro Antibody Protein 52

Drug Discovery World

APRIL 13, 2023

The Biology Unveiled track will feature scientific sessions focusing on the hot topic of personalised medicine, along with advances in the uses of CRISPR and vessels-on-a-chip. SLAS Europe has revealed details of the Biology Unveiled track at the upcoming meeting in Brussels, Belgium on May 23-26. View the Full SLAS Europe 2023 Programme.

In-Vitro 52

In-Vitro Genome Genomics Engineer 52

Scienmag

OCTOBER 9, 2020

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralized SARS-CoV-2 infection in cultured cells, according to a new study.

In-Vitro 40

In-Vitro Antibody Allergies Medicine 40

Drug Discovery World

OCTOBER 21, 2022

Bertis, a South Korean proteomics-based precision medicine technology company, has established a US-based wholly-owned entity to expand its global presence. The test received marketing approval as an in vitro diagnostic medical device from the Ministry of Food and Drug Safety in January 2019.

In-Vitro 52

In-Vitro Protein Medicine Research 52

Drug Discovery World

OCTOBER 30, 2023

Through this collaboration, the companies will build on results published earlier this year, which evidenced the in vitro activation of HERV-W by SARS-CoV-2 in susceptible individuals and the correlation between W-ENV protein levels in serum and lymphocytes with Covid-19 severity. “Our

In-Vitro 52

In-Vitro Protein Medicine Drugs 52

Scienmag

JUNE 29, 2021

Oncotarget published “High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC” which reported that the aim of […].

In-Vivo 96

In-Vivo In-Vitro Protein Medicine 96

Drug Discovery World

OCTOBER 31, 2023

The free summit, sponsored by Taconic, will offer expert thought leadership on cancer research, precision medicine and immunotherapy. Raffi Tonikian DDW is delighted to confirm that the event will feature a talk by Dr Raffi Tonikian, Director of Translational Biomarkers at AbCellera, sharing his broad expertise in autoimmunity and oncology.

In-Vitro 52

In-Vitro Research Medicine Development 52

Drug Discovery World

MARCH 8, 2024

In vitro assays have shown superiority over the marketed monoclonal antibodies to respective target. In particular, the introduction of biologics for severe asthma paved the way to a true revolution in the field of asthma management, by potentially allowing a precision medicine approach.

Antibody 52

Antibody Trials In-Vitro Clinical Trials 52

Drug Discovery World

FEBRUARY 13, 2024

It has demonstrated efficacy in in vitro and in vivo models of fibrosis, as well as favourable safety and pharmacokinetic profiles in Phase I clinical studies. It has demonstrated efficacy in in vitro and in vivo models of fibrosis, as well as favourable safety and pharmacokinetic profiles in Phase I clinical studies.

Drugs 52

Drugs In-Vivo In-Vitro Medicine 52

The Pharma Data

AUGUST 24, 2020

Parties to adopt multi-phase approach to develop precision medicine strategies to optimize treatment of cardiovascular, renal and metabolic disease. AstraZeneca has linked with RenalytixAI to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases. Source link.

In-Vitro 52

In-Vitro Medicine Development Trials 52

Drug Discovery World

MARCH 19, 2024

DDW’s Diana Spencer speaks to Elaine Duncan, a PhD student on the lifETIME (Engineered Tissues for Discovery, Industry and Medicine) CDT at the University of Glasgow. DS: Can you tell us what you do and what you’re working on at the moment? ED : I’m currently a PhD researcher at the University of Glasgow. The environment in eg.

Research 59

Research In-Vitro Drugs Engineer 59

Scienmag

DECEMBER 11, 2020

10, 2020) — An in vitro study published in theJournal of Dietary Supplements, demonstrated Blue California’s ErgoActive® ergothioneine helped to preserve telomere length and reduced the rate of telomere shortening under oxidative stress. The in vitro study is […].

In-Vitro 53

In-Vitro Allergies Medicine 53

Drug Discovery World

AUGUST 3, 2023

Founded in 2011, the company delivers discovery solutions across medicinal, synthetic, scale-up, process and computational chemistry, as well as DMPK, in vitro biology and in vivo pharmacology. This is the third acquisition by Sygnature over the last sixteen months, following the investment by Five Arrows in Summer 2021.

In-Vivo 52

In-Vivo In-Vitro Protein Marketing 52

Scienmag

OCTOBER 18, 2020

18, 2020) – Success rates for in vitro fertilization are higher at clinics that voluntarily share more information than required by government regulators, according to new research by faculty at the University of Colorado School of Medicine. AURORA, Colo.

In-Vitro 40

In-Vitro Regulation Medicine Research 40

Drug Discovery World

JUNE 30, 2023

Research tools, safety testing and regenerative medicines – these endless stem cell applications are powering precision, speed, and new modalities in drug development. Stem cells for use in drug discovery Stem cells are fast becoming an invaluable tool in the drug discovery process. This article is sponsored by Charles River.

Development 52

Development Drugs In-Vitro Gene Therapy 52

Scienmag

MAY 7, 2021

government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies. . – Peer reviewed by medical experts that included three U.S.

In-Vitro 80

In-Vitro Research Scientist Medicine 80

Drug Discovery World

OCTOBER 25, 2023

Data generated by our laboratory across in vitro and in vivo models and from human clinical samples support this important finding. Previous attempts to interrupt TGF-β pathway signaling in cancer have been thwarted by activation of alternative resistance pathways by the tumour.

Research 52

Research In-Vivo In-Vitro Clinical Development 52

Drug Discovery World

APRIL 25, 2023

We have reached an important milestone with the dosing of the second participant in our clinical trial evaluating a potentially groundbreaking CAR-T cell therapy to cure HIV,” said Mehrdad Abedi, Professor of Internal Medicine, Hematology and Oncology and co-investigator of the study. “So In 2021 there were an estimated 1.5

Research 52

Research In-Vitro Clinical Trials Clinical Trials 52

Scienmag

JANUARY 28, 2021

Researchers demonstrated its potential therapeutic efficacy in two in vitro model systems using beating heart cells reengineered from the blood samples of […]. ROCHESTER, Minn.

Gene Therapy 74

Gene Therapy Gene In-Vitro Clinical Research 74

Drug Discovery World

OCTOBER 2, 2023

The Nobel Assembly at Karolinska Institutet has awarded the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries that enabled the development of mRNA vaccines against Covid-19. The discovery had profound significance for using mRNA as therapy. Image credit: Ill.

In-Vitro 65

In-Vitro Protein Vaccination Vaccine 65